Anne Aupérin

Avelumab–cetuximab–radiotherapy versus standards of care in locally advanced squamous-cell carcinoma of the head and neck: The safety phase of a randomised phase III trial GORTEC 2017-01 (REACH)

Yungan Tao, Anne Aupérin, Xu-Shan Sun et al. · European Journal of Cancer · 2020 · 97 citations · Full text

Medicine, Oncology, Radiation Oncology +11

A prospective multicentre REFCOR study of 470 cases of head and neck Adenoid cystic carcinoma: epidemiology and prognostic factors

Sarah Atallah, Odile Casiraghi, Nicolas Fakhry et al. · European Journal of Cancer · 2020 · 85 citations · Full text

Medicine, Neck Surgery, Oncology +6

TPExtreme randomized trial: TPEx versus Extreme regimen in 1st line recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC).

J. Guigay, Jérôme Fayette, Cédrik Lafond et al. · Journal of Clinical Oncology · 2019 · 82 citations

Medicine, Oncology, Pharmacology +14

NIVOPOSTOP (GORTEC 2018-01): A phase III randomized trial of adjuvant nivolumab added to radio-chemotherapy in patients with resected head and neck squamous cell carcinoma at high risk of relapse.

Jean Bourhis, Anne Aupérin, Christian Borel et al. · Journal of Clinical Oncology · 2025 · 53 citations

Medicine, Oncology, Surgery +17

Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients

Pierre Blanchard, Anne W.M. Lee, Alexandra Carmel et al. · Clinical and Translational Radiation Oncology · 2021 · 44 citations · Full text

Medicine, Oncology, Radiation Oncology +11